GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Ever Fortune.AI Co Ltd (ROCO:6841) » Definitions » Debt-to-EBITDA

Ever Fortune.AI Co (ROCO:6841) Debt-to-EBITDA : 0.04 (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Ever Fortune.AI Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Ever Fortune.AI Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was NT$2.8 Mil. Ever Fortune.AI Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was NT$2.4 Mil. Ever Fortune.AI Co's annualized EBITDA for the quarter that ended in Mar. 2025 was NT$125.4 Mil. Ever Fortune.AI Co's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2025 was 0.04.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Ever Fortune.AI Co's Debt-to-EBITDA or its related term are showing as below:

ROCO:6841' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.15   Med: -0.05   Max: 0.08
Current: 0.04

During the past 7 years, the highest Debt-to-EBITDA Ratio of Ever Fortune.AI Co was 0.08. The lowest was -0.15. And the median was -0.05.

ROCO:6841's Debt-to-EBITDA is ranked better than
96.72% of 458 companies
in the Healthcare Providers & Services industry
Industry Median: 2.465 vs ROCO:6841: 0.04

Ever Fortune.AI Co Debt-to-EBITDA Historical Data

The historical data trend for Ever Fortune.AI Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ever Fortune.AI Co Debt-to-EBITDA Chart

Ever Fortune.AI Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-EBITDA
Get a 7-Day Free Trial -0.05 -0.06 0.02 -0.15 0.08

Ever Fortune.AI Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 0.02 0.13 0.03 0.04

Competitive Comparison of Ever Fortune.AI Co's Debt-to-EBITDA

For the Health Information Services subindustry, Ever Fortune.AI Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ever Fortune.AI Co's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Ever Fortune.AI Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Ever Fortune.AI Co's Debt-to-EBITDA falls into.


;
;

Ever Fortune.AI Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Ever Fortune.AI Co's Debt-to-EBITDA for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(3.349 + 3.042) / 77.965
=0.08

Ever Fortune.AI Co's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(2.804 + 2.379) / 125.38
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2025) EBITDA data.


Ever Fortune.AI Co  (ROCO:6841) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Ever Fortune.AI Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Ever Fortune.AI Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Ever Fortune.AI Co Business Description

Traded in Other Exchanges
N/A
Address
Jingmao Road, 8th Floor, No. 360, Section 1, Beitun District, Taichung, TWN, 406040
Ever Fortune.AI Co Ltd is composed of establishing a cloud medical platform based on medical big data, and to provide customized medical artificial intelligence solutions and services in various biomedical fields. The results both provide a professional second opinion for doctors and assist clinical doctors in making a medical diagnosis, which in turn raises the speed, accuracy, and efficiency of medical decisions. The products of the company include: Medical Artificial Intelligence, Cloud Biomedical Platform, and Medical Big Data. Its segments are: Medical AI Department; Biotechnology Department; and Others, where maximum revenue is derived from Biotechnology Department segment.

Ever Fortune.AI Co Headlines

No Headlines